P-glycoprotein And Multidrug Resistance: Structure-activity Relationships Of Modulators [glicoproteína-p, Resistência A Múltiplas Drogas (mdr) E Relação Estrutura-atividade De Moduladores]

Multidrug resistance, MDR is a major obstacle for cancer chemotherapy. MDR can be reversed by drugs that vary in their chemical structure and main biological activity. Many efforts have been done to overcome MDR based on studies of structure-activity relationships and in this review we summarize some aspects of MDR mediated by P-glycoprotein (P-gp), as the most experimentally and clinically tested form of drug resistance. The most significant MDR mechanisms revealed until now are shortly discussed. Physicochemical and structural properties of MDR modulators, measures of the MDR reversal, and QSAR studies are included.

2148

2154

Longley, D.B., Johnston, P.G., (2005) J. Pathol., 205, p. 275

Hill, B., (1996) Int. J. Oncol., 9, p. 197

Mitscher, L.A., Pillai, S.P., Gentry, E.J., Shankel, D.M., (1999) Med. Res. Rev., 19, p. 477

Dewick, P.M., (2009) Medicinal Natural Products, a Biosynthetic Approach, , 3rd ed., Wiley: United Kingdom

Dietel, M., (1991) Pathol. Res. Pract., 187, p. 892

Beck, W.T., (1990) Cancer Treat. Rev., 17, p. 11

Morrow, C.S., Cowan, K.H., (1990) Cancer Cell., 2, p. 15

Hammond, J.R., Johnstone, R.M., Gros, P., (1989) Cancer Res., 49, p. 3867

Hannun, Y.A., (1977) Blood, 89, p. 1845

Szakacs, G., Paterson, J.K., Ludwig, J.A., Booth-Genthe, C., Gottesman, M.M., (2006) Nat. Rev. Drug Discovery, 5, p. 219

Kessel, D., Bottenrill, V., Wodinsky, I., (1968) Cancer Res., 28, p. 938

Jones, P.M., George, A.M., (1998) J. Membr. Biol., 166, p. 133

Robert, J., (1997) Drugs Fut, 22, p. 149

Juliano, R.L., Ling, V., (1976) Biochim. Biophys. Acta, 455, p. 152

Ruetz, S., Gros, P., (1994) Cell., 77, p. 1071

Borst, P., Evers, R., Kool, M., Wijnholds, J., (2000) J. Nat. Cancer Inst., 92, p. 1295

Hipfner, D.R., Deeley, R.G., Cole, S.P.C., (1999) Biochim. Biophys. Acta, 1461, p. 359

Litman, T., Druley, T.E., Stein, W.D., Bates, S.E., (2001) Cell. Mol. Life Sci., 58, p. 931

Deeley, R.G., Cole, S.P.C., (1997) Cancer Biol., 8, p. 193

Gatti, L., Beretta, G.L., Cossa, G., Zunino, F., Perego, P., (2009) Mini-Rev. Med. Chem., 9, p. 1102

Gottesmann, M.M., Pastan, I., (1993) Annu. Rev. Biochem., 62, p. 385

King, M., Su, W., Chang, A., Zuckerman, A., Pasternak, G.W., (2001) Nature Neurosci., 4, p. 268

Liu, X.D., Liu, G.Q., (2001) Acta Pharmacol. Sin., 22, p. 111

Raviv, Y., Pollard, H.B., Bruggemann, E.P., Pastan, I., Gottesmann, M.M., (1990) J. Biol. Chem., 265, p. 3975

Stein, W.D., (1977) Phys. Rev., 77, p. 545

Higgins, C.F., (1994) Cell., 79, p. 393

Dawson, R.J.P., Locher, K.P., (2006) Nature, 443, p. 180

Stenham, D.R., Campbell, J.D., Sansom, M.S.P., Higgins, C.F., Kerr, I.D., Linton, K.J., (2003) FASEB J., 17, p. 2287

Locher, K.P., Lee, A.T., Rees, D.C., (2002) Science, 296, p. 1091

Hollenstein, K., Frei, K.P., Locher, K.P., (2007) Nature, 446, p. 213

Pinkett, H.W., Lee, A.T., Lum, P., Locher, K.P., Rees, D.C., (2007) Science, 315, p. 373

Oldham, M.L., Khare, D., Quiocho, F.A., Davidson, A.L., Chen, J., (2007) Nature, 450, p. 515

Rosenberg, M.F., Kamis, A.B., Callaghan, R., Higgins, C.F., Ford, J., (2003) J. Biol. Chem., 278, p. 8294

Lee, J.-Y., Urbatsch, I.L., Senior, A.E., Wilkens, S., (2008) J. Biol. Chem., 283, p. 5769

Aller, S.G., Yu, J., Ward, A., Weng, Y., Chittaboina, S., Zhuo, R., Harrell, P.M., Chang, G., (2009) Science, 323, p. 1718

Loo, T.W., Bartlett, M.C., Clarke, D.M., (2003) J. Biol. Chem., 278, p. 39706

Zamora, J.M., Pearce, H.L., Beck, W.T., (1988) Biochem. Pharmacol., 33, p. 454

Pajeva, I.K., Wiese, M., (1997) QSAR, 16, p. 1

Wiese, M., Pajeva, I.K., (2001) Curr. Med. Chem., 8, p. 685

Biedler, J.R., Riehm, H., (1970) Cancer Res., 30, p. 1174

Selassie, C.D., Hansch, C., Khwaja, T.A., (1990) J. Med. Chem., 33, p. 1914

Ueda, K., Taguchi, Y., Morishima, M.S., (1997) Cancer Biol., 8, p. 151

Rauch, C., Farge, E., (2000) Biophys. J., 78, p. 3036

Rauch, C., Pluen, A., (2007) Eur. Biophys. J., 36, p. 121

Rauch, C., (2009) Eur. Biophys. J., 38, p. 537

Ekins, S., Kim, R.B., Leake, B.F., Dantzig, A.H., Schuetz, E.G., Lan, L.-B., Yasuda, K.Y., Wrighton, S.A., (2002) Mol. Pharmacol., 61, p. 964

Seelig, A., (1998) Int. J. Clin. Pharmacol. Ther., 36, p. 54

Robert, J., Jarry, C., (2003) J. Med. Chem., 46, p. 4805

Ueda, K., Okamura, N., Hirai, M., Tanigawara, Y., Saeki, T., Kioka, N., Komano, T., Hori, R., (1992) J. Biol. Chem., 267, p. 24248

Ecker, G., Huber, M., Schmid, D., Chiba, P., (1999) Mol. Pharmacol., 56, p. 791

Gopinath, V.S., Thimmaiah, P., Thimmaiah, K.N., (2008) Bioorg. Med. Chem., 16, p. 474. , Um exemplo de protocolo pode ser encontrado em

Jekerle, V., Klinkhammer, W., Scollard, D.A., Breitbach, K., Reilly, R.M., Piquette-Miller, M., Wiese, M., (2006) Int. J. Cancer, 119, p. 414

Ramalhete, C., Molnar, J., Silva, M., Rosário, V.E., Ferreira, M.-J.U., (2009) Bioorg. Med. Chem., 17, p. 6942

Dhainaut, A., Regnier, G., Atassi, C., Pierre, A., Leonce, S., Kraus-BeRthier, L., Prost, J.-F., (1992) J. Med. Chem., 35, p. 2481

Safa, A.R., (1999) Drug Res. Updates, 2, p. 371

Taub, M.E., Podila, L., Almeida, I., (2005) Drug Metab. Dispos, 33, p. 1679

Ford, J.M., Bruggeman, E.P., Pastan, I., Gottesmann, M., Hait, W.N., (1990) Cancer Res., 50, p. 1748

Pearce, H.L., Winter, M.A., Beck, W.T., (1990) Adv. Enzyme Regul, 30, p. 357

Thomas, H., Coley, H.M., (2003) Cancer Control, 10, p. 159

Dey, S., (2000) Curr. Opin. Inv. Drugs, 3, p. 818

Rago, R.P., Einstein, A., Lush, R., Beer, T.M., Ko, Y.J., Henner, W.D., Bubley, G., Dalton, V.S., (2003) Cancer Chemother. Pharmacol., 51, p. 297

Minderman, H., O'Loughlin, K.L., Pendyala, L., Baer, M.R., (2004) Clin. Cancer Res., 10, p. 1826

Kaiser, D., Terfloth, L., Kopp, S., Schulz, J., De Laet, R., Chiba, P., Ecker, G.F., Gasteiger, J., (2007) J. Med. Chem., 50, p. 1698

Ferrer-Montiel, A., Messeguer, A., Ferragut, J.A., Pérez-Payá, E., Masip, I., Cortés, N., Abdad-Merin, M.J., (2005) J. Pharmacol. Exp. Ther., 313, p. 112

Bisi, A., Gobbi, S., Rampa, A., Belluti, F., Piazzi, L., Valenti, P., Gyemant, N., Molnár, J., (2006) J. Med. Chem., 49, p. 3049

Huber, P.C., Pettenazzi, M.C.R., Kohn, L.K., Tormena, C.F., Almeida, W.P., (2009) 10th Tetrahedron. Symposium, , Paris, France

Traunecker, H.C., Stevens, M.C., Kerr, M.C., Ferry, D.R., (1999) Br. J. Cancer, 81, p. 942

Sparreboom, A., Plantings, A.S., Jewell, R.C., Van Der Gaast, A., De Bruijn, P., Loos, W.J., Nooter, K., Verweij, J., (1999) Anti-cancer Drugs, 10, p. 719

Pusztai, L., Wagner, P., Ibrahim, N., Rivera, E., Theriault, R., Booser, D., Symmans, F.W., Hortobagyi, G.N., (2005) Cancer, 104, p. 682

Walker, J., Martin, C., Callaghan, R., (2004) Eur. J. Cancer, 40, p. 594. , e referências citadas

McDevitt, C.A., Callaghan, R., (2007) Pharmacol. Ther., 113, p. 429

Colafubo, N.A., Berardi, F., Cantore, M., Perrone, M.G., Contino, M., Inglese, C., Niso, M., Paradiso, A., (2008) Bioorg. Med. Chem., 16, p. 362

Talegaonkar, S., Khar, R.K., Jaggi, M., Akhtar, N., Bansal, T., (2009) DDT, 14, p. 1067

Chavanpatil, M.D., Patil, Y., Panyam, J., (2006) Int. J. Pharm., 320, p. 150

Chavanpatil, M.D., Khdair, A., Gerard, B., Bachmeier, C., Miller, D.W., Shekhar, M.P.V., Panyam, J., (2007) Mol. Pharmacol., 4, p. 730

Patil, Y., Sadhukha, T., Ma, L., Panyam, J., (2009) J. Controlled Release, 136, p. 21

Tachibana, T., Kitamura, S., Kato, M., Mitsui, T., Shirasaka, Y., Yamashita, S., Sugiyama, Y., (2010) Pharm. Res., 27, p. 442

Siarheyeva, A., Liu, R., Sharom, F.J., (2010) J. Biol. Chem., 285, p. 7575

Borska, S., Sopel, M., Chmielewska, M., Zabel, M., Dziegiel, P., (2010) Molecules, 15, p. 857

Sun, L.-R., Cui, S.-X., Qu, X.-J., (2010) Drugs Fut, 34, p. 53

Riveiro, M.E., De Kimpe, N., Moglioni, A., Vazquez, R., Monczor, F., Shayo, C., Davio, C., (2010) Curr. Med. Chem., 17, p. 1325

Singh, P., Kaur, J., Bhardwaj, A., (2010) Eur. J. Med. Chem., 45, p. 1256

Colabufo, N.A., Berardi, F., Cantore, M., Contino, M., Inglese, C., Niso, M., Perrone, R., (2010) J. Med. Chem., 53, p. 1883

Materias

Mostrar el registro completo del ítem